As of the latest Form 4 filed Jun 17, 2026.
What Moderna Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 36 most recent filings for MRNA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | 2026-06-15 | Hoge Stephen President | SSale | −53.3K | $51.37 | $2.74M | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Hoge Stephen, President | MExercise | +16.1K | $19.15 | $309K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Hoge Stephen, President | MExercise | +37.2K | $19.15 | $713K | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Klinger Shannon Thyme Chief Legal Officer | FTax | −5.71K | $51.59 | $294K | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Klinger Shannon Thyme, Chief Legal Officer | MExercise | +11.8K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Mock James M Chief Financial Officer | FTax | −5.71K | $51.59 | $294K | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-05 | Mock James M, Chief Financial Officer | MExercise | +11.8K | — | — | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Klinger Shannon Thyme Chief Legal Officer | SSale | −3.47K | $50.00 | $174K | Yes (planned) | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Klinger Shannon Thyme, Chief Legal Officer | MExercise | +3.47K | $30.96 | $107K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Mock James M Chief Financial Officer | FTax | −1.20K | $47.19 | $56.5K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Mock James M, Chief Financial Officer | MExercise | +2.48K | — | — | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Klinger Shannon Thyme Chief Legal Officer | FTax | −1.05K | $47.19 | $49.4K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Klinger Shannon Thyme, Chief Legal Officer | MExercise | +2.17K | — | — | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Hoge Stephen President | FTax | −4.49K | $47.19 | $212K | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Hoge Stephen, President | MExercise | +9.28K | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Mock James M Chief Financial Officer | FTax | −159.00 | $47.61 | $7.57K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Mock James M, Chief Financial Officer | MExercise | +328.00 | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Klinger Shannon Thyme Chief Legal Officer | FTax | −159.00 | $47.61 | $7.57K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Klinger Shannon Thyme, Chief Legal Officer | MExercise | +328.00 | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Hoge Stephen President | FTax | −295.00 | $47.61 | $14.0K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Hoge Stephen, President | MExercise | +610.00 | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Mock James M Chief Financial Officer | FTax | −374.00 | $47.03 | $17.6K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Mock James M, Chief Financial Officer | MExercise | +773.00 | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Klinger Shannon Thyme Chief Legal Officer | FTax | −374.00 | $47.03 | $17.6K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Klinger Shannon Thyme, Chief Legal Officer | MExercise | +773.00 | — | — | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Hoge Stephen President | FTax | −695.00 | $47.03 | $32.7K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-27 | Hoge Stephen, President | MExercise | +1.44K | — | — | No | Form 4 ↗ |
| 2026-05-04 | 2026-05-01 | Hussain Abbas Director | SSale | −5.68K | $46.63 | $265K | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Horning Sandra Director | MExercise | +16.2K | — | — | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Rubenstein David M. Director | MExercise | +8.12K | — | — | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Hussain Abbas Director | MExercise | +16.2K | — | — | Yes (planned) | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | NABEL ELIZABETH G Director | MExercise | +16.2K | — | — | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Nader Francois Director | MExercise | +12.2K | — | — | No | Form 4 ↗ |
| 2026-05-04 | 2026-04-30 | Tallett Elizabeth E Director | MExercise | +4.06K | — | — | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Mock James M Chief Financial Officer | FTax | −703.00 | $50.03 | $35.2K | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | Mock James M, Chief Financial Officer | MExercise | +1.45K | — | — | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also MRNA’s full analysis or the market-wide insider trading feed. The tabs above jump to MRNA’s other SEC data.
Source: SEC Form 4 filings for MRNA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.